Median Technologies inks dev deal with Medidata for cloud-based imaging tech

Median Technologies (EPA:ALMDT) and Medidata said today they inked a collaborative deal looking to leverage their capabilities to streamline the growth and use of medical imaging in cancer clinical trials. Through the deal, Median Technologies will use Medidata’s Clinical Cloud to accelerate oncology medicine development, the companies said. Median will also use Medidata’s Medical Imaging system to transition its existing legacy imaging study management systems to a single digital environment, the companies said. “Our collaboration with Medidata will not only ease the management of images during clinical drug trials—it will enhance our analytical rigor, enabling our teams to extract high-quality imaging biomarkers for better study and patient outcomes. Medidata’s imaging technology provides us with complementary capabilities to fulfill the unique R&D needs of our growing customer-base in Europe, Asia and the US. We’re dedicated to helping biopharmaceutical companies make more informed decisions to quickly bring new cancer therapies to market, and are thrilled to partner with Medidata to aid in those efforts,” Median Tech COO Jeanne Hecht said in a press release. “We are excited about our collaboration with Median, an organization that is setting the gold standard for diagnosing disease, developing new therapies and treating patients through the use of medical images. Medidata considers the entire image management process, turning the c...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Clinical Trials Imaging Median Technologies Medidata Solutions Source Type: news